Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ObsteCare is a Swedish women's health and obstetric medtech company focused on improving intrapartum care during labor. Its core commercial product is the AFL Monitoring System, a point-of-care diagnostic system that measures lactate in amniotic fluid to support assessment and management of dysfunctional or arrested labor. The company markets its AFL method as a tool to improve labor management, reduce unnecessary interventions, and support safer births for mothers and infants. ObsteCare appears to operate as a small, publicly traded company based in Solna, Sweden, with distribution efforts extending beyond the Nordics into parts of Europe, Africa, and historically North America through partners. The business is centered on commercial-stage medical devices and consumables rather than a therapeutic drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ObsteCare.